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Imagine the frustration. You are a stroke clinician who endeavours to provide evidence-
based care to your patients. You read a randomised trial of an intervention and after 
critically appraising it, decide that there is sufficiently strong evidence for the intervention to 
be implemented in your stroke service. You go back to the Methods section of the paper and 
look for the details of the intervention. It contains some broad details but they are insufficient 
for you to know how to use the intervention with your patients. You remain unclear about the 
number, length and content of the sessions, as well as the content of and materials used to 
train the clinicians in the intervention. What happens next? 
Unfortunately this problem is not uncommon. One barrier to using evidence-based 
interventions, which surprisingly has received little attention to date, is that interventions are 
often not reported in sufficient detail to enable their use - rendering a large proportion of 
health research unusable and contributing to $100 billion per year of worldwide research 
waste (1).   
While this is a problem for all interventions, perhaps unsurprisingly, the problem of poor 
intervention reporting is greater for non-pharmacological interventions. An analysis of the 
intervention reporting in 137 non-pharmacological interventions from 133 trials found that 
only 39% were described adequately in the publication, references, appendices or websites to 
enable the intervention to be replicated (2). Crucial intervention information, such as details 
about the procedure used, intensity of the intervention, or the physical and information 
materials used, were missing from the majority of trials - thereby preventing clinicians from 
using the interventions with their patients. While some additional details could be obtained by 
contacting the study authors (increasing the adequately described interventions to 59%), it is 
unrealistic to expect clinicians to perform this additional step and nor should they have to.   
Incomplete intervention descriptions also hinder stroke research, frequently impeding others 
from replicating and building on existing research. Stroke rehabilitation has been described as 
a ‘black box’ (3), with limited knowledge about the effective components and features of the 
intervention (for example, optimal intensity, duration, and timing). A need for rehabilitation 
to be standardised based on the best evidence has been identified as one of the priorities of 
the stroke world agenda (4, 5). One of the ways that researchers can contribute to 
advancement of this goal is by adequately describing the interventions that they evaluate.    
The inadequacy of intervention reporting is compounded as evidence is synthesised, such as 
in systematic reviews and clinical guidelines. This is partly due to information missing in 
primary trial reports, but also due to lack of awareness of the issue by those who write and 
publish reviews and guidelines. A recent analysis of a random sample of 60 systematic 
reviews of non-pharmacological stroke interventions found that most reviews were missing 
intervention information for the majority of items (6). The usability and interpretation of 
systematic reviews are therefore hampered by incomplete intervention descriptions, affecting 
both authors and users of systematic reviews. For systematic review authors, many steps in 
the review process, such as decisions about inclusion and meta-analysis, are made 
particularly difficult if they have to ‘guess’ at intervention details. Users of guidelines have 
identified that lack of knowledge in ‘how to do’ the interventions and unhelpful broad 
guideline recommendations were major barriers to implementing stroke guideline 
recommendations (7). 
The causes of poor intervention reporting are likely to be multi-factorial. While initiatives to 
improve the reporting of trials and trial protocols such as the CONSORT (8) and SPIRIT (9) 
reporting statements have had some success, sufficient guidance about how to describe 
interventions has not existed. There is a lack of awareness among authors about what 
comprises a complete intervention description as well as a lack of attention to this issue by 
peer reviewers and editors (10) and in journal instructions to authors (11).  
Part of the solution to poor intervention reporting is to provide authors with guidance about 
how to structure accounts of their interventions. In 2014, the Template for Intervention 
Description and Replication (TIDieR) checklist and guide was published (12). TIDieR is an 
official extension of the CONSORT statement (item 5) and the SPIRIT statement (item 11) 
and was designed to be used in conjunction with these statements. While the emphasis of 
TIDieR is on its use with randomised trials, it can be used with any evaluative study design, 
including systematic reviews. The TIDieR guide acknowledges that providing complete 
intervention descriptions may increase the word count of a paper and offers suggestions for 
how authors may manage this, including providing details in published protocols and online 
supplementary materials - which 75% of journals now have the capacity to host (11).  
We urge the stroke research community, including authors, peer reviewers and journal 
editors, to ensure that full and detailed accounts of study interventions are provided in 
publications so that stroke patients can receive evidence-based care. 
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